TRIM58 Interacts with ZEB1 to Suppress NSCLC Tumor Malignancy by Promoting ZEB1 Protein Degradation via UPP.

Authors:
Shang R; Chen J; Gao Y; Chen J; Han G.

Journal:
Dis Markers

Publication Year: 2023

DOI:
10.1155/2023/5899662

PMCID:
PMC9836804

PMID:
36644609

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Dis Markers

Abbreviation: Dis Markers

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Biochemistry

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Circulating Nucleic Acids in Colorectal Cancer: Diagnostic and Prognostic Value.
Igder S; Zamani M; Fakher S and 4 more (2024) - Transparency Score: 3/6
Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios in Distinguishing Lung Cancer in People with H…
Baluku JB; Namiiro S; Namanda B and 7 more (2024) - Transparency Score: 3/6
Arterial Hypertension and Its Consequences Are the Main Predictors of Embolic Stroke of Undetermine…
Berdalin AB; Namestnikova DD; Cherkashova EA and 3 more (2023) - Transparency Score: 4/6
Association between Serum Cys C and PTB Cavitation.
Tan S; Wu D; Wu Y and 3 more (2023) - Transparency Score: 3/6
Characterization of TIM-3 Expression and Its Correlation with TNF-<i>α</i> and IFN-<i>γ</i> in Pati…
Tan J; Shen P; Yang X and 2 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of Interest The authors declare that there is no conflict of interest."

Evidence found in paper:

"The study was funded by the Second Affiliated Hospital of Air Force Medical University."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025